Drug Shortage Report for SANDOZ ROSUVASTATIN

Last updated on 2018-04-13 History
Report ID 29168
Drug Identification Number 02338734
Brand name SANDOZ ROSUVASTATIN
Common or Proper name ROSUVASTATIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ROSUVASTATIN
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100'S
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-10-30
Estimated end date 2018-03-30
Actual end date 2018-03-23
Shortage status Resolved
Updated date 2018-04-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2018-04-13 French Compare
v7 2018-04-13 English Compare
v6 2018-02-05 French Compare
v5 2018-02-05 English Compare
v4 2017-11-27 French Compare
v3 2017-11-27 English Compare
v2 2017-11-14 French Compare
v1 2017-11-14 English Compare

Showing 1 to 8 of 8